Clinical Trial Detail

NCT ID NCT04117087
Title Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

colorectal cancer

pancreatic cancer

Therapies

Ipilimumab + Nivolumab + Poly ICLC

Age Groups: adult senior

No variant requirements are available.